Genome Editing Testing Core
Genome Editing Testing Core
批准号:
10599929
负责人:
DAVID J SEGAL
金额:
$93.79万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-04-15 至 2025-03-31
关键词:
AccelerationAddressAnimalsB-LymphocytesBiological AssayBiological MarkersBiopsyBloodBlood CellsBrainBreedingCaliforniaCallithrixCell physiologyCellsCenter for Translational Science ActivitiesClinical ChemistryClinical SciencesCollaborationsComplete Blood CountDataEarEnsureEpigenetic ProcessEvaluationEventEyeFemaleFundingGenesGenomeGenomic DNAGenotypeGoalsGonadal structureHeartHematopoietic SystemHistologicHomeostasisImmune responseImmunologyIn VitroInflammationInfrastructureInnate Immune ResponseKidneyLipidsLiverLungMacaca mulattaMeasurementMetabolicMethodologyMethodsMuscleNatural ImmunityNon-Viral VectorOrganPerformancePopulationPositron-Emission TomographyPrimatesProceduresReagentReporterReportingReproducibilityResearchResearch PersonnelResolutionResourcesRhesusSafetySex DifferencesSkinSpecificitySystemT-LymphocyteTechniquesTechnologyTestingTimeTissuesTranslationsUnited States National Institutes of HealthValidationViral VectorVisualizationWorkX-Ray Computed Tomographyadaptive immune responseadaptive immunitybody systembonecell typechromatin immunoprecipitationcost effectivedetection assayflexibilitygenome editinghuman diseaseimmunogenicityin vivoin vivo imagingmalemultidisciplinarynew technologynonhuman primateoff-target siteoptical imagingprogramssafety assessmentsafety testingsingle-cell RNA sequencingsomatic cell gene editingtoolworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Genome Editing Testing Core
PROJECT SUMMARY / ABSTRACT
The overarching goal of the Genome Editing Testing Core is to test the function of reagents and genome
editing tools developed by investigators funded through other components of the Somatic Cell Genome Editing
(SCGE) Program. The Genome Editing Testing Core will work directly with SCGE awardees and expand
established standard operating procedures (SOPs) and develop new assays for detection of genome editing in
wild-type and reporter nonhuman primates. The Genome Editing Testing Core will test the efficiency and
specificity of editing and will assess the safety and immunogenicity of the genome editing technologies and
delivery systems. The Genome Editing Testing Core has all of the essential facilities and capabilities required
to test a range of viral and non-viral vectors developed by SCGE awardees. The Genome Editing Testing Core
will contribute to the acceleration of the translation of genome editing technologies into treatments for human
diseases through the following Specific Aims: (1) Evaluate genome editing in cells and tissues, (2) Address
safety and the potential for inflammation and immune responses, and (3) Validation of reporter nonhuman
primates. The Genome Editing Testing Core team has the expertise and flexibility to work with investigators to
quantify any desired type of genome editing event in both rhesus macaques and marmosets (e.g., on-target,
off-target, large rearrangements, duration of editing, cell specificity), and in any organ system or cell
population. Paired with a robust Coordination Component and the Resource Core, and through the
infrastructure of the UC Davis Genome Center, California National Primate Research Center, and Clinical and
Translational Science Center, the Genome Editing Testing Core will deliver the data needed to
comprehensively assess the promise of new technologies developed by SCGE awardees.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genome Editing and Biological Effects Testing Component
-
批准号:10773949
-
项目类别:
-
资助金额:$65.19万
-
财政年份:2023
-
负责人:DAVID J SEGAL
-
依托单位:
Innovative Translational Imaging Technologies to Monitor Genome Edited Cells in Vivo
-
批准号:10472034
-
项目类别:
-
资助金额:$47.13万
-
财政年份:2021
-
负责人:DAVID J SEGAL
-
依托单位:
Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools: Equipment Supplement
-
批准号:10330336
-
项目类别:
-
资助金额:$9.72万
-
财政年份:2021
-
负责人:DAVID J SEGAL
-
依托单位:
Innovative Translational Imaging Technologies to Monitor Genome Edited Cells in Vivo
-
批准号:10447268
-
项目类别:
-
资助金额:$46.4万
-
财政年份:2021
-
负责人:DAVID J SEGAL
-
依托单位:
Innovative Translational Imaging Technologies to Monitor Genome Edited Cells in Vivo
-
批准号:9810511
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2019
-
负责人:DAVID J SEGAL
-
依托单位:
Genome Editing Testing Core
-
批准号:10380051
-
项目类别:
-
资助金额:$104.38万
-
财政年份:2019
-
负责人:DAVID J SEGAL
-
依托单位:
Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools
-
批准号:9770048
-
项目类别:
-
资助金额:$116.87万
-
财政年份:2019
-
负责人:DAVID J SEGAL
-
依托单位:
Innovative Translational Imaging Technologies to Monitor Genome Edited Cells in Vivo
-
批准号:10017228
-
项目类别:
-
资助金额:$22.79万
-
财政年份:2019
-
负责人:DAVID J SEGAL
-
依托单位:
Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools
-
批准号:9905568
-
项目类别:
-
资助金额:$116.14万
-
财政年份:2019
-
负责人:DAVID J SEGAL
-
依托单位:
Determinants of Persistence in Epigenetic Editing
-
批准号:9920184
-
项目类别:
-
资助金额:$18.72万
-
财政年份:2019
-
负责人:DAVID J SEGAL
-
依托单位:
Genome Editing Testing Core
-
批准号:10133176
-
项目类别:
-
资助金额:$98.39万
-
财政年份:2019
-
负责人:DAVID J SEGAL
-
依托单位:
CRISPR-based epigenetic modifier
-
批准号:9369533
-
项目类别:
-
资助金额:$2.31万
-
财政年份:2017
-
负责人:DAVID J SEGAL
-
依托单位:
CRISPR-based epigenetic modifiers
-
批准号:9480886
-
项目类别:
-
资助金额:$6.85万
-
财政年份:2016
-
负责人:DAVID J SEGAL
-
依托单位:
CRISPR-based epigenetic modifiers
-
批准号:9301498
-
项目类别:
-
资助金额:$31.63万
-
财政年份:2016
-
负责人:DAVID J SEGAL
-
依托单位:
NextGen DNA Binding Proteins Based on TAL Domains
-
批准号:8641394
-
项目类别:
-
资助金额:$27.75万
-
财政年份:2011
-
负责人:DAVID J SEGAL
-
依托单位:
NextGen DNA Binding Proteins Based on TAL Domains
-
批准号:8449290
-
项目类别:
-
资助金额:$26.87万
-
财政年份:2011
-
负责人:DAVID J SEGAL
-
依托单位:
NextGen DNA Binding Proteins Based on TAL Domains
-
批准号:8245004
-
项目类别:
-
资助金额:$27.95万
-
财政年份:2011
-
负责人:DAVID J SEGAL
-
依托单位:
NextGen DNA Binding Proteins Based on TAL Domains
-
批准号:8083281
-
项目类别:
-
资助金额:$26.91万
-
财政年份:2011
-
负责人:DAVID J SEGAL
-
依托单位:
Towards Gene Therapy for Angelman Syndrome
-
批准号:7970962
-
项目类别:
-
资助金额:$17.91万
-
财政年份:2010
-
负责人:DAVID J SEGAL
-
依托单位:
Towards Gene Therapy for Angelman Syndrome
-
批准号:8139031
-
项目类别:
-
资助金额:$21.25万
-
财政年份:2010
-
负责人:DAVID J SEGAL
-
依托单位:
海外基金